Primary and secondary prevention of metabolic and cardiovascular comorbidities in women with polycystic ovary syndrome

被引：3
作者：
Spritzer, Poli Mara [1 ]
机构：
[1] Hosp Clin Porto Alegre, Div Endocrinol, Rua Raniro Barcelos 2350, BR-90035003 Porto Alegre, RS, Brazil
来源：
REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA | 2015年 / 37卷 / 01期
关键词：
D O I：
10.1590/SO100-720320140005212
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：1 / 4
页数：4
相关论文
共 50 条
  • [21] Cardiovascular risk in women with polycystic ovary syndrome
    Orio, Francesco
    Palomba, Stefano
    Colao, Annamaria
    FERTILITY AND STERILITY, 2006, 86 : S20 - S21
  • [22] Cardiovascular risk in women with polycystic ovary syndrome
    Talbott, EO
    Zborowski, JV
    Sutton-Tyrrell, K
    McHugh-Pemu, KP
    Guzick, DS
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2001, 28 (01) : 111 - +
  • [23] Metabolic and cardiovascular changes in patients with polycystic ovary syndrome
    Meden-Vrtovec, E
    Vrtovec, B
    Osredkar, J
    Human Reproduction, 2005, : 316 - 320
  • [24] Primary and secondary prevention of gestational diabetes by metformin therapy during pregnancy in women with polycystic ovary syndrome.
    Glueck, C. J.
    Pranikoff, J.
    Aregawi, D.
    Wang, P.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (02) : S361 - S361
  • [25] Polycystic ovary syndrome: a reproductive and metabolic web of risk, comorbidities, and disease
    Bates, G. Wright, Jr.
    FERTILITY AND STERILITY, 2019, 111 (03) : 471 - 472
  • [26] Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
    Rasool, Shayaq Ul Abeer
    Ashraf, Sairish
    Nabi, Mudasar
    Rashid, Fouzia
    Fazili, Khalid Majid
    Amin, Shajrul
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (03) : 2098 - 2105
  • [27] Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome
    Christakou, Charikleia D.
    Diamanti-Kandarakis, Evanthia
    WOMENS HEALTH, 2008, 4 (06) : 583 - 594
  • [28] The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome
    Sahin, Yilmaz
    Unluhizarci, Kursad
    Yilmazsoy, Ayse
    Yikilmaz, Ali
    Aygen, Ercan
    Kelestimur, Fahrettin
    CLINICAL ENDOCRINOLOGY, 2007, 67 (06) : 904 - 908
  • [29] Metabolic syndrome in young Czech women with polycystic ovary syndrome
    Vrbíková, J
    Vondra, K
    Cibula, D
    Dvoráková, K
    Stanická, S
    Srámková, D
    Sindelka, G
    Hill, M
    Bendlová, B
    Skrha, J
    HUMAN REPRODUCTION, 2005, 20 (12) : 3328 - 3332
  • [30] The metabolic syndrome in young Korean women with polycystic ovary syndrome
    Park, Hwi Ra
    Choi, Youngju
    Lee, Hye-Jin
    Oh, Jee-Young
    Hong, Young Sun
    Sung, Yeon-Ah
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 77 : S243 - S246
12345